| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| AR protein | 14 | 0 | 0 | 14 |
| glucocorticoid receptor [Homo sapiens] | 11 | 0 | 0 | 11 |
| thyroid hormone receptor beta isoform a | 6 | 0 | 0 | 6 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 7 | 0 | 0 | 7 |
| geminin | 11 | 0 | 0 | 11 |
| Sex hormone-binding globulin | 0 | 0 | 3 | 3 |
| Corticosteroid-binding globulin | 0 | 4 | 0 | 4 |
| Mineralocorticoid receptor | 0 | 3 | 4 | 7 |
| Androgen receptor | 0 | 3 | 0 | 3 |
| Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A1 | 0 | 2 | 0 | 3 |
| Guanine nucleotide-binding protein G | 1 | 0 | 0 | 1 |
| Chain A, 2-oxoglutarate Oxygenase | 4 | 0 | 0 | 4 |
| Microtubule-associated protein tau | 5 | 0 | 0 | 5 |
| thioredoxin glutathione reductase | 5 | 0 | 0 | 5 |
| Smad3 | 2 | 0 | 0 | 2 |
| euchromatic histone-lysine N-methyltransferase 2 | 11 | 0 | 0 | 11 |
| microphthalmia-associated transcription factor isoform 9 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 1 | 0 | 3 | 0 | 3 |
| Carbonic anhydrase 2 | 0 | 3 | 1 | 4 |
| Tyrosine-protein phosphatase non-receptor type 1 | 0 | 0 | 1 | 1 |
| Chain A, Vitamin D Nuclear Receptor | 0 | 0 | 1 | 1 |
| Chain A, Beta-lactamase | 3 | 0 | 0 | 3 |
| Chain A, Ferritin light chain | 2 | 0 | 0 | 2 |
| Vitamin D3 receptor | 0 | 0 | 1 | 1 |
| USP1 protein, partial | 7 | 0 | 0 | 7 |
| PPM1D protein | 2 | 0 | 0 | 2 |
| mitogen-activated protein kinase 1 | 2 | 0 | 0 | 2 |
| nuclear receptor ROR-gamma isoform 1 | 5 | 0 | 0 | 5 |
| peripheral myelin protein 22 | 3 | 0 | 0 | 3 |
| ATP-binding cassette sub-family C member 3 | 0 | 11 | 0 | 11 |
| Multidrug resistance-associated protein 4 | 0 | 11 | 0 | 12 |
| Bile salt export pump | 0 | 15 | 0 | 15 |
| Interferon beta | 7 | 0 | 0 | 7 |
| Vitamin D-binding protein | 0 | 0 | 1 | 1 |
| Cytochrome P450 1A2 | 0 | 1 | 0 | 2 |
| Cytochrome P450 3A4 | 0 | 6 | 0 | 7 |
| Androgen receptor | 0 | 4 | 0 | 4 |
| Cytochrome P450 2D6 | 0 | 1 | 0 | 1 |
| Vitamin D3 receptor | 0 | 1 | 2 | 4 |
| Cytochrome P450 2C9 | 0 | 5 | 0 | 6 |
| Vitamin D3 receptor | 0 | 1 | 1 | 3 |
| Retinoic acid receptor RXR-alpha | 0 | 0 | 3 | 3 |
| Cytochrome P450 2C19 | 0 | 3 | 0 | 4 |
| Kappa-type opioid receptor | 0 | 0 | 1 | 1 |
| Vitamin D3 receptor | 0 | 0 | 1 | 1 |
| 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | 0 | 0 | 1 | 1 |
| Vitamin D3 receptor | 0 | 1 | 1 | 2 |
| Transporter | 0 | 1 | 0 | 1 |
| Canalicular multispecific organic anion transporter 1 | 0 | 12 | 0 | 13 |
| Vitamin D3 receptor A | 0 | 0 | 2 | 2 |
| Chain A, HADH2 protein | 5 | 0 | 0 | 5 |
| Chain B, HADH2 protein | 5 | 0 | 0 | 5 |
| thioredoxin reductase | 5 | 0 | 0 | 5 |
| pregnane X receptor | 3 | 0 | 0 | 3 |
| RAR-related orphan receptor gamma | 10 | 0 | 0 | 10 |
| NFKB1 protein, partial | 1 | 0 | 0 | 1 |
| GALC protein | 3 | 0 | 0 | 3 |
| TDP1 protein | 11 | 0 | 0 | 11 |
| GLI family zinc finger 3 | 10 | 0 | 0 | 10 |
| Thrombopoietin | 1 | 0 | 0 | 1 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 2 | 0 | 0 | 2 |
| progesterone receptor | 10 | 0 | 0 | 10 |
| nonstructural protein 1 | 1 | 0 | 0 | 1 |
| retinoic acid nuclear receptor alpha variant 1 | 8 | 0 | 0 | 8 |
| retinoid X nuclear receptor alpha | 9 | 0 | 0 | 9 |
| estrogen-related nuclear receptor alpha | 9 | 0 | 0 | 9 |
| farnesoid X nuclear receptor | 6 | 0 | 0 | 6 |
| pregnane X nuclear receptor | 13 | 0 | 0 | 13 |
| estrogen nuclear receptor alpha | 15 | 0 | 0 | 15 |
| G | 3 | 0 | 0 | 3 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 11 | 0 | 0 | 11 |
| IDH1 | 3 | 0 | 0 | 3 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 7 | 0 | 0 | 7 |
| thyroid stimulating hormone receptor | 3 | 0 | 0 | 3 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 6 | 0 | 0 | 6 |
| chromobox protein homolog 1 | 8 | 0 | 0 | 8 |
| thyroid hormone receptor beta isoform 2 | 9 | 0 | 0 | 9 |
| heat shock protein beta-1 | 4 | 0 | 0 | 4 |
| serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 11 | 0 | 0 | 11 |
| survival motor neuron protein isoform d | 4 | 0 | 0 | 4 |
| cytochrome P450 3A4 isoform 1 | 4 | 0 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit pi | 4 | 0 | 1 | 5 |
| Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 1 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
| HLA class I histocompatibility antigen, B alpha chain | 3 | 0 | 0 | 3 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 4 | 0 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit delta | 4 | 0 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 4 | 0 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 4 | 0 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 4 | 0 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 4 | 0 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 4 | 0 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 4 | 0 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 4 | 0 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 4 | 0 | 1 | 5 |
| C-8 sterol isomerase | 0 | 1 | 0 | 1 |
| Nuclear receptor ROR-gamma | 3 | 1 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 4 | 0 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 4 | 0 | 1 | 5 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 4 | 0 | 1 | 5 |
| 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 1 | 0 | 2 | 0 | 2 |
| GABA theta subunit | 4 | 0 | 1 | 5 |
| Inositol hexakisphosphate kinase 1 | 3 | 0 | 0 | 3 |
| Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | 4 | 0 | 1 | 5 |
| Solute carrier family 22 member 2 | 0 | 2 | 0 | 2 |
| cytochrome P450 2C9, partial | 3 | 0 | 0 | 3 |
| endonuclease IV | 1 | 0 | 0 | 1 |
| dopamine D1 receptor | 3 | 0 | 0 | 3 |
| GLS protein | 2 | 0 | 0 | 2 |
| aldehyde dehydrogenase 1 family, member A1 | 6 | 0 | 0 | 6 |
| regulator of G-protein signaling 4 | 3 | 0 | 0 | 3 |
| peroxisome proliferator-activated receptor delta | 8 | 0 | 0 | 8 |
| peroxisome proliferator activated receptor gamma | 8 | 0 | 0 | 8 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 7 | 0 | 0 | 7 |
| peripheral myelin protein 22 isoform 1 | 1 | 0 | 0 | 1 |
| atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
| flap endonuclease 1 | 2 | 0 | 0 | 2 |
| M-phase phosphoprotein 8 | 2 | 0 | 0 | 2 |
| muscarinic acetylcholine receptor M1 | 1 | 0 | 0 | 1 |
| Glucocorticoid receptor | 0 | 6 | 2 | 13 |
| Glycine receptor subunit alpha-1 | 0 | 6 | 0 | 6 |
| Glycine receptor subunit beta | 0 | 6 | 0 | 6 |
| Glycine receptor subunit alpha-2 | 0 | 6 | 0 | 6 |
| Glycine receptor subunit alpha-3 | 0 | 6 | 0 | 6 |
| Potassium voltage-gated channel subfamily A member 1 | 0 | 0 | 1 | 1 |
| TAR DNA-binding protein 43 | 2 | 0 | 0 | 2 |
| Multidrug and toxin extrusion protein 1 | 0 | 1 | 0 | 1 |
| Sodium- and chloride-dependent creatine transporter 1 | 0 | 1 | 0 | 1 |
| Proton-coupled amino acid transporter 1 | 0 | 1 | 0 | 1 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 5 | 0 | 0 | 5 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
| Chain A, Cruzipain | 2 | 0 | 0 | 2 |
| interleukin 8 | 2 | 0 | 0 | 2 |
| PAX8 | 0 | 0 | 0 | 1 |
| SMAD family member 2 | 3 | 0 | 0 | 3 |
| ATAD5 protein, partial | 4 | 0 | 0 | 4 |
| SMAD family member 3 | 3 | 0 | 0 | 3 |
| STAT3, partial | 0 | 1 | 0 | 1 |
| estrogen receptor 2 (ER beta) | 5 | 0 | 0 | 5 |
| nuclear receptor subfamily 1, group I, member 3 | 8 | 0 | 0 | 8 |
| 67.9K protein | 4 | 0 | 0 | 4 |
| alpha-galactosidase | 2 | 0 | 0 | 2 |
| activating transcription factor 6 | 3 | 0 | 0 | 3 |
| NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
| cellular tumor antigen p53 isoform a | 2 | 0 | 0 | 2 |
| tumor necrosis factor | 1 | 0 | 0 | 1 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
| ras-related protein Rab-9A | 1 | 0 | 0 | 1 |
| signal transducer and activator of transcription 1-alpha/beta isoform alpha | 0 | 1 | 0 | 1 |
| lethal factor (plasmid) | 1 | 0 | 0 | 1 |
| lamin isoform A-delta10 | 5 | 0 | 0 | 5 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 3 | 0 | 6 |
| Voltage-dependent calcium channel gamma-2 subunit | 5 | 0 | 0 | 5 |
| Cellular tumor antigen p53 | 8 | 0 | 0 | 8 |
| Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 3 | 0 | 3 |
| Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 3 | 0 | 3 |
| Integrin beta-3 | 2 | 0 | 0 | 2 |
| Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
| Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 4 | 0 | 6 |
| Integrin alpha-IIb | 2 | 0 | 0 | 2 |
| Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 2 | 0 | 2 |
| Sodium/potassium-transporting ATPase subunit beta-2 | 0 | 2 | 0 | 2 |
| Glutamate receptor 2 | 5 | 0 | 0 | 5 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
| Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 3 | 0 | 3 |
| Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 1 | 0 | 1 |
| Sodium/potassium-transporting ATPase subunit beta-3 | 0 | 2 | 0 | 2 |
| Sodium/potassium-transporting ATPase subunit gamma | 0 | 2 | 0 | 2 |
| Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 2 | 0 | 2 |
| Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 4C1 | 0 | 1 | 0 | 3 |
| Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 2 |
| ATPase family AAA domain-containing protein 5 | 4 | 0 | 0 | 4 |
| Ataxin-2 | 4 | 0 | 0 | 4 |
| Solute carrier organic anion transporter family member 1A4 | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 5 | 0 | 8 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 3 | 0 | 6 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 6 | 0 | 0 | 6 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 2 | 0 | 6 |
| Pantothenate synthetase | 0 | 2 | 0 | 2 |
| glp-1 receptor, partial | 2 | 0 | 0 | 2 |
| hypoxia-inducible factor 1 alpha subunit | 3 | 0 | 0 | 3 |
| caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
| caspase-3 | 1 | 0 | 0 | 1 |
| LMP1 [Human herpesvirus 4] | 0 | 0 | 0 | 1 |
| Histone H2A.x | 2 | 0 | 0 | 2 |
| nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | 0 | 2 | 0 | 2 |
| DNA polymerase iota isoform a (long) | 3 | 0 | 0 | 3 |
| urokinase-type plasminogen activator precursor | 1 | 0 | 0 | 1 |
| plasminogen precursor | 1 | 0 | 0 | 1 |
| urokinase plasminogen activator surface receptor precursor | 1 | 0 | 0 | 1 |
| transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 2 | 0 | 2 |
| nuclear receptor coactivator 3 isoform a | 0 | 2 | 0 | 2 |
| Prothrombin | 0 | 0 | 1 | 2 |
| Regulatory protein E2 | 0 | 0 | 1 | 1 |
| DNA topoisomerase 1 | 0 | 1 | 0 | 2 |
| DNA topoisomerase 2-alpha | 0 | 1 | 1 | 7 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 2 | 0 | 2 |
| DNA topoisomerase 2 | 0 | 0 | 0 | 1 |
| UDP-glucuronosyltransferase 1A1 | 0 | 2 | 0 | 3 |
| Serum paraoxonase/arylesterase 1 | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 0 | 0 | 1 |
| Caspase-3 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 0 | 0 | 1 |
| DNA topoisomerase 2-alpha | 0 | 0 | 0 | 1 |
| DNA topoisomerase 2-beta | 0 | 1 | 1 | 8 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 0 | 0 | 1 |
| Tubulin beta-2B chain | 0 | 1 | 0 | 1 |
| Integrase | 0 | 1 | 0 | 1 |
| Similar to alpha-tubulin isoform 1 | 0 | 1 | 0 | 1 |
| Similar to alpha-tubulin isoform 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 0 | 0 | 1 |
| aryl hydrocarbon receptor | 6 | 0 | 0 | 6 |
| nuclear receptor subfamily 1, group I, member 2 | 2 | 0 | 0 | 2 |
| EWS/FLI fusion protein | 5 | 0 | 0 | 5 |
| Spike glycoprotein | 3 | 0 | 0 | 3 |
| importin subunit beta-1 isoform 1 | 2 | 0 | 0 | 2 |
| snurportin-1 | 2 | 0 | 0 | 2 |
| GTP-binding nuclear protein Ran isoform 1 | 1 | 0 | 0 | 1 |
| Luciferase | 2 | 0 | 0 | 2 |
| phosphopantetheinyl transferase | 3 | 0 | 0 | 3 |
| bromodomain adjacent to zinc finger domain 2B | 2 | 0 | 0 | 2 |
| 3-oxoacyl-[acyl-carrier-protein] synthase 3 | 0 | 1 | 0 | 1 |
| cytochrome P450 2D6 isoform 1 | 1 | 0 | 0 | 1 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 1 | 0 | 0 | 1 |
| histone acetyltransferase KAT2A isoform 1 | 3 | 0 | 0 | 3 |
| N-glycosylase/DNA lyase | 0 | 1 | 0 | 1 |
| Polyphenol oxidase 2 | 0 | 1 | 0 | 1 |
| Bile salt export pump | 0 | 5 | 0 | 5 |
| Myeloperoxidase | 0 | 1 | 0 | 1 |
| Formamidopyrimidine-DNA glycosylase | 0 | 1 | 0 | 1 |
| DNA gyrase subunit A | 0 | 1 | 0 | 1 |
| DNA gyrase subunit B | 0 | 1 | 0 | 1 |
| Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2A6 | 0 | 1 | 0 | 1 |
| Macrophage migration inhibitory factor | 0 | 1 | 0 | 1 |
| Endonuclease III-like protein 1 | 0 | 1 | 0 | 1 |
| DNA gyrase subunit B | 0 | 2 | 0 | 2 |
| DNA gyrase subunit A | 0 | 2 | 0 | 2 |
| Isocitrate lyase | 0 | 1 | 0 | 1 |
| Putative FAD-containing monooxygenase MymA | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Endonuclease 8-like 1 | 0 | 1 | 0 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 2 | 0 | 0 | 2 |
| Chain B, DIHYDROFOLATE REDUCTASE | 0 | 0 | 1 | 1 |
| acid sphingomyelinase | 1 | 0 | 0 | 1 |
| ClpP | 2 | 0 | 0 | 2 |
| 15-lipoxygenase, partial | 2 | 0 | 0 | 2 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Bloom syndrome protein isoform 1 | 1 | 0 | 0 | 1 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 2 | 0 | 0 | 2 |
| vitamin D3 receptor isoform VDRA | 4 | 0 | 0 | 4 |
| transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
| DNA polymerase beta | 1 | 0 | 0 | 1 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 2 | 0 | 0 | 2 |
| DNA polymerase eta isoform 1 | 2 | 0 | 0 | 2 |
| DNA polymerase kappa isoform 1 | 2 | 0 | 0 | 2 |
| muscleblind-like protein 1 isoform 1 | 2 | 0 | 0 | 2 |
| caspase-1 isoform alpha precursor | 1 | 0 | 0 | 1 |
| Toll-like receptor 4 | 0 | 1 | 0 | 1 |
| Fatty-acid amide hydrolase 1 | 0 | 1 | 0 | 1 |
| ATP-binding cassette sub-family C member 3 | 0 | 1 | 0 | 2 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 3 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase ABL1 | 0 | 0 | 1 | 1 |
| Thymidylate synthase | 0 | 2 | 0 | 2 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 2 |
| High mobility group protein B1 | 0 | 0 | 1 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 2 | 4 |
| Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Folate receptor beta | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
| Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
| Folate receptor alpha | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Histidine decarboxylase | 0 | 1 | 0 | 1 |
| Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 2 | 0 | 0 | 1 | 1 |
| Bifunctional purine biosynthesis protein ATIC | 0 | 2 | 0 | 2 |
| Multidrug resistance-associated protein 1 | 0 | 0 | 0 | 1 |
| Delta-type opioid receptor | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
| Reduced folate transporter | 0 | 2 | 0 | 2 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
| 6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
| Caspase-7 | 1 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A3 | 0 | 0 | 0 | 3 |
| Pteridine reductase 1 | 0 | 1 | 0 | 1 |
| Folylpolyglutamate synthase, mitochondrial | 0 | 1 | 0 | 3 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 0 | 0 | 1 |
| Canalicular multispecific organic anion transporter 1 | 0 | 1 | 0 | 2 |
| Trifunctional purine biosynthetic protein adenosine-3 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| ATP-binding cassette sub-family C member 11 | 0 | 0 | 0 | 1 |
| Proton-coupled folate transporter | 0 | 1 | 0 | 1 |
| Multidrug resistance associated protein | 0 | 1 | 0 | 2 |
| Solute carrier family 22 member 11 | 0 | 0 | 0 | 1 |
| Protein-arginine deiminase type-4 | 0 | 3 | 0 | 3 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 2 | 0 | 3 |
| ATP-dependent phosphofructokinase | 1 | 0 | 0 | 1 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 1 | 0 | 0 | 1 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
| acetylcholinesterase | 1 | 0 | 0 | 1 |
| Mcl-1 | 0 | 1 | 0 | 1 |
| apical membrane antigen 1, AMA1 | 3 | 0 | 0 | 3 |
| cytochrome P450 2C19 precursor | 1 | 0 | 0 | 1 |
| huntingtin isoform 2 | 1 | 0 | 0 | 1 |
| pyruvate kinase PKM isoform a | 1 | 0 | 0 | 1 |
| serine/threonine-protein kinase PLK1 | 2 | 0 | 0 | 2 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 2 | 0 | 0 | 2 |
| cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | 0 | 1 | 0 | 1 |
| Bifunctional cytochrome P450/NADPH--P450 reductase | 0 | 0 | 1 | 1 |
| UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 1 |
| Potassium-transporting ATPase subunit beta | 0 | 1 | 0 | 1 |
| Potassium-transporting ATPase alpha chain 1 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1-6 | 0 | 1 | 0 | 1 |
| Potassium-transporting ATPase alpha chain 1 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A4 | 0 | 1 | 0 | 1 |
| Bombesin receptor subtype-3 | 0 | 0 | 1 | 1 |
| UDP-glucuronosyltransferase 2B10 | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 2 | 0 | 0 | 2 |
| Fatty acid synthase | 0 | 2 | 0 | 2 |
| Potassium-transporting ATPase subunit beta | 0 | 1 | 0 | 1 |
| Cytochrome P450 2J2 | 0 | 2 | 0 | 2 |
| Potassium-transporting ATPase alpha chain 2 | 0 | 0 | 0 | 1 |
| WD repeat-containing protein 5 | 0 | 1 | 0 | 1 |
| Glutathione S-transferase omega-1 | 0 | 2 | 0 | 2 |
| Histone-lysine N-methyltransferase 2A | 0 | 1 | 0 | 1 |
| Cytosolic endo-beta-N-acetylglucosaminidase | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor | 0 | 1 | 0 | 1 |
| Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
| Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
| Vasopressin V2 receptor | 0 | 1 | 1 | 2 |
| Oxytocin receptor | 0 | 2 | 2 | 4 |
| Vasopressin V1a receptor | 0 | 1 | 0 | 1 |
| Vasopressin V1a receptor | 0 | 2 | 1 | 3 |
| Vasopressin V1b receptor | 0 | 1 | 1 | 2 |
| Vasopressin V1b receptor | 0 | 1 | 0 | 1 |
| Oxytocin receptor | 0 | 1 | 0 | 1 |
| Oxytocin receptor | 0 | 0 | 1 | 1 |
| Vasopressin V2 receptor | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 4 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 9 | 0 | 1 | 0 | 1 |
| luciferase | 0 | 0 | 0 | 1 |
| Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
| Estrogen receptor | 0 | 2 | 0 | 2 |
| Progesterone receptor | 0 | 2 | 0 | 3 |
| Glucocorticoid receptor | 0 | 1 | 1 | 2 |
| Glucocorticoid receptor | 0 | 0 | 1 | 1 |
| Glutamine synthetase | 0 | 0 | 1 | 1 |
| Histamine H1 receptor | 0 | 0 | 1 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Nociceptin receptor | 0 | 0 | 1 | 1 |
| Estrogen receptor beta | 0 | 2 | 0 | 2 |
| thyroid stimulating hormone receptor | 2 | 0 | 0 | 2 |
| arylsulfatase A | 1 | 0 | 0 | 1 |
| NAD-dependent protein deacetylase sirtuin-6 | 0 | 1 | 0 | 1 |
| DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
| Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 2 |
| Albumin | 0 | 0 | 1 | 1 |
| NH(3)-dependent NAD(+) synthetase | 0 | 1 | 0 | 1 |
| 60 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| Cytochrome P450 2B6 | 0 | 0 | 1 | 1 |
| Arylacetamide deacetylase | 0 | 1 | 0 | 2 |
| Caspase-1 | 0 | 1 | 0 | 1 |
| Alpha-synuclein | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1A2 | 0 | 1 | 0 | 3 |
| 10 kDa heat shock protein, mitochondrial | 0 | 1 | 0 | 1 |
| DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
| Thiosulfate sulfurtransferase | 0 | 1 | 0 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 1 | 0 | 1 |
| 60 kDa chaperonin | 0 | 1 | 0 | 1 |
| 10 kDa chaperonin | 0 | 1 | 0 | 1 |
| Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 2 | 2 |
| Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 2 | 2 |
| Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 2 |
| Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
| Transthyretin | 0 | 1 | 0 | 3 |
| Thyroid hormone receptor alpha | 0 | 2 | 3 | 5 |
| Thyroid hormone receptor beta | 0 | 2 | 3 | 5 |
| Proliferating cell nuclear antigen | 0 | 2 | 0 | 2 |
| Peroxisome proliferator-activated receptor gamma | 0 | 0 | 4 | 4 |
| Malate dehydrogenase, mitochondrial | 0 | 1 | 0 | 1 |
| Monocarboxylate transporter 8 | 0 | 0 | 0 | 1 |
| Bile acid receptor | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1C1 | 0 | 0 | 0 | 1 |
| glucocerebrosidase | 1 | 0 | 0 | 1 |
| neuropeptide S receptor isoform A | 1 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
| Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit epsilon | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 4A1 | 0 | 0 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1C1 | 0 | 1 | 0 | 1 |
| Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |